MOBILE
"Modelling, Optimization and Control of Biomedical Systems"
| Coordinatore | IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Totale costo | 1˙782˙925 € |
| EC contributo | 1˙782˙925 € |
| Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | ERC-2008-AdG |
| Funding Scheme | ERC-AG |
| Anno di inizio | 2009 |
| Periodo (anno-mese-giorno) | 2009-01-01 - 2013-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | hostInstitution | 1˙782˙925.00 |
| 2 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | hostInstitution | 1˙782˙925.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The main aim of the proposed project is to develop models and model based control and optimization methods and tools for drug delivery systems, which would ensure: (i) Reliable and fast calculation of the optimal drug dosage without the need for an on-line computer while taking into account the specifics and constraints of the patient model (personalised health care) (ii) Flexibility to adapt to changing patient characteristics, (iii) Incorporation of the physician s performance criteria (iv) Safety of the patients (v) Reduced size effects by optimising the drug infusion rates The overall control and optimisation approach will rely on the novel multi-parametric model-based control technology developed by the PI over the past 15 years, which will be further extended and implemented in the context of the following biomedical systems (a) insulin delivery (b) control of anaesthesia and hemodynamic variables, (c) optimal chemotherapy design for anti-cancer (d) optimal control of the chemotherapy for HIV.'